February 22, 2019 SMITHS FALLS, ON — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) is pleased to announce the appointment of Dr. Danial Schecter as Director of Global Medical Services. Dr. Schecter is widely recognized as an expert in the clinical use of medical cannabis and will use his experience to expand the Company’s network of partner healthcare clinics and support doctors and patients who understand the value of cannabis as medicine. “I have had the honour of serving a range of patients who, after exhausting traditional pharmaceutical approaches, have reported the remarkable benefits of therapeutic cannabis,”…

February 20, 2019 SMITHS FALLS, ON – Canopy Growth Corporation (TSX:WEED) (NYSE: CGC) (“Canopy Growth” or “the Company) filed its Amended and Restated Management Discussion and Analysis for the three and nine months ended December 31, 2018 (“Amended MD&A”) to correct the Adjusted EBITDA1 in the original MD&A for the nine months ended December 31, 2018 filed on February 14, 2019 (the “Original MD&A”), as follows. The correction of the Adjusted EBITDA loss for the nine months ended December 31, 2018 from $69,006,000 to $155,154,000. The correction was made due to a formula error in the spreadsheet supporting the year…

Laval (Québec) & Smiths Falls (Ontario) Canada – February 21, 2019 – Alimentation Couche-Tard Inc. (“Alimentation-Couche-Tard”) (TSX: ATD.A) (TSX: ATD.B) has entered into a multi-year agreement with Canopy Growth Corporation (“Canopy Growth”) (TSX: WEED, NYSE: CGC). Subsequent to this newly formed strategic partnership, and pending the results of a public-consultation process, Alimentation Couche-Tard is excited to announce it has entered into a trademark license agreement with one of the winners of the Alcohol and Gaming Commission of Ontario’s (the “AGCO”) Expression of Interest Application Lottery, who will operate a “Tweed” branded retail store in London, Ontario, once the process is…

February 7, 2019 SMITHS FALLS, ON — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED, NYSE: CGC) is pleased to announce that it intends to increase its total investment in Canopy Rivers Inc. (“Canopy Rivers”) (TSXV: RIV) by $30 million (CDN). The investment will be made through a private placement of subordinated voting shares in the capital of Canopy Rivers (the “Subordinate Voting Shares”) concurrent with Canopy Rivers bought deal offering of Subordinate Voting Shares for gross proceeds of approximately $55 million. This investment is being co-led by CIBC Capital Markets and Eight Capital and is expected to…

High-quality medical cannabis available today in Polish pharmacies; UK presence positions Spectrum to lead in a key emerging market. January 21, 2019 Smiths Falls, Canada, Oxford, UK, Toruń, Poland – Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) (“Canopy Growth” or the “Company”) is pleased to update key European progress in the UK and Poland where its medically-focused business Spectrum Cannabis continues to build a sophisticated, pan-European cannabis production and distribution network serving the needs of physicians and their patients throughout the continent. United Kingdom In the United Kingdom the Company has formed Spectrum Biomedical UK, a new company focused on providing access…